TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07819773: Evaluation of the Efficacy and Safety of an Accelerated Protocol for Treating Generalized Anxiety Disorder Using the BTL-699-2 Device

Sponsor: BTL Industries Ltd. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 40 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$6,573,600

Rescue Site Savings

+$4,349,200

Unlock Full NCT07819773 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07819773 Rescue Dossier →